• Reuters


Canadian drugmaker Tekmira Pharmaceuticals Corp. has begun limited manufacturing of a drug targeting the Ebola-Guinea virus.

Tekmira said Tuesday that the product would be available by early December but did not specify how many doses it was making.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.